•
Sep 28, 2024

Thermo Fisher Q3 2024 Earnings Report

Thermo Fisher's financial performance remained stable in Q3 2024, marked by strategic advancements and partnerships.

Key Takeaways

Thermo Fisher Scientific reported third-quarter revenue of $10.60 billion and GAAP diluted EPS of $4.25. The company is raising its full-year adjusted EPS guidance to a new range of $21.35 to $22.07.

Third quarter revenue was $10.60 billion.

Third quarter GAAP diluted earnings per share (EPS) was $4.25.

Third quarter adjusted EPS was $5.28.

The company launched innovative new products, including the Thermo Scientific Iliad scanning transmission electron microscope and the Applied Biosystems MagMAX Sequential DNA/RNA kit.

Total Revenue
$10.6B
Previous year: $10.6B
+0.2%
EPS
$5.28
Previous year: $5.69
-7.2%
Gross Profit
$4.33B
Previous year: $4.43B
-2.3%
Cash and Equivalents
$4.65B
Previous year: $6.15B
-24.5%
Free Cash Flow
$1.92B
Previous year: $2.15B
-10.8%
Total Assets
$100B
Previous year: $97.1B
+3.4%

Thermo Fisher

Thermo Fisher

Thermo Fisher Revenue by Segment

Forward Guidance

Thermo Fisher is raising its full-year adjusted EPS guidance to a new range of $21.35 to $22.07 versus its previous guidance of $21.29 to $22.07. Revenue guidance continues to be in the range of $42.4 to $43.3 billion.

Revenue & Expenses

Visualization of income flow from segment revenue to net income